Clinical Trial Detail

NCT ID NCT03817125
Title Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention (MCGRAW)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Parker Institute for Cancer Immunotherapy
Indications

skin melanoma

mucosal melanoma

acral lentiginous melanoma

Therapies

Nivolumab + SER-401

Vancomycin

Nivolumab

Age Groups: adult senior

No variant requirements are available.